SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-025281
Filing Date
2024-06-26
Accepted
2024-06-26 16:35:41
Documents
20
Period of Report
2024-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54677
2 ex1-1.htm EX-1.1 199513
3 ex4-1.htm EX-4.1 131634
4 ex5-1.htm EX-5.1 20017
5 ex99-1.htm EX-99.1 13939
6 ex99-2.htm EX-99.2 12328
7 ex99-3.htm EX-99.3 11221
8 ex5-1_001.jpg GRAPHIC 4926
  Complete submission text file 0001493152-24-025281.txt   713635

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ogen-20240625.xsd EX-101.SCH 3018
10 XBRL LABEL FILE ogen-20240625_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE ogen-20240625_pre.xml EX-101.PRE 22361
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3699
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 241073872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)